Dr. Ebony Hoskins, a board-certified gynecologic oncologist at MedStar Washington Hospital Center, said data showed combining immunotherapy with chemotherapy had improved progression-free survival.

Carrie Madormo, RN, MPH, is a health writer. She has over a decade of experience as a registered nurse, practicing in a variety of fields, such as pediatrics, oncology, chronic pain, and public ...

Pesticides have gained negative attention in recent years owing to their links to biodiversity loss. But could pesticides ...

Jemperli is a monoclonal antibody targeting PD-1, an inhibitory immunological checkpoint receptor, which activates an ...

Ovarian cancer is a relatively manageable malignancy when diagnosed at an early stage, but late-stage detection almost always translates into a poor prognosis. Researchers have been vigorously ...

Proteomic signatures in blood plasma and cervicovaginal fluid for endometrial cancer detection. Study uncovers proteomic signatures in blood plasma and cervicovaginal fluid that could lead to non ...

A new nomogram is intended to identify patients at high risk for endometrial cancer and prioritize them in the hysteroscopy ...

Endometrial cancer is also known as uterine cancer, which occurs in the lining of the uterus (endometrium). It is 4th most common cancer among women. There are various treatment options available.

Serous endometrial cancers make up approximately 5% of endometrial cancer cases, but account for about 40% of deaths from the disease. It is an aggressive subtype with poor outcomes. About 30% of ...

The FDA accepted the supplemental biologics license for dostarlimab plus standard-of-care chemotherapy for all patients with ...

Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have received two new three-year, $1 million grants from the U.S. Department of Defense to a ...

Endometrial cancer is a type of cancer that begins in the inner lining of the uterus—known as the endometrium. The ...